NEO Operating Cash Flow Growth
Neogenomics Inc · Operating Cash Flow Growth
NEO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported56.94%period ending
NEO TTM Cash from Operations YoY % (46.64% → 56.94%)
Year-over-year change
High-resolution chart · PNG
NEO operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 56.9436% | |
| 194.5736% | |
| -25.5304% | |
| -8.7959% | |
| 5,221.5909% | |
| 150.1516% | |
| 459.6006% | |
| 164.0722% | |
| 100.772% | |
| 69.431% | |
| 97.0406% | |
| 71.4658% | |
| 53.5234% | |
| 14.3653% | |
| -146.9521% | |
| -8,432.6403% | |
| -1,103.6693% | |
| -646.7604% | |
| -1,930.3425% | |
| 17.4957% | |
| -56.7288% | |
| 2.5534% | |
| -93.7524% | |
| -103.2879% | |
| -32.7965% | |
| -71.729% | |
| -47.8207% | |
| 1.0572% | |
| -26.1721% | |
| 7.4512% | |
| 148.3007% | |
| 191.5344% | |
| 140.0661% | |
| 162.3121% | |
| -16.0171% | |
| -49.5071% | |
| -14.2668% | |
| -7.2949% | |
| 235.9456% | |
| 353.3853% | |
| 174.2767% | |
| 83.2417% | |
| -32.3492% | |
| -33.9364% | |
| -13.4868% | |
| 66.6958% | |
| 324.3377% | |
| 191.2184% | |
| 27,868% | |
| 705.284% | |
| 552.6423% | |
| 266.3539% | |
| -97.8051% | |
| -238.1387% | |
| -813.0435% | |
| 192.2126% | |
| 170.3956% | |
| 126.9685% | |
| 103.3626% | |
| 71.7874% | |
| 34.1162% | |
| 25.6462% | |
| -36.762% | |
| -186.0218% | |
| -1,545.0895% | |
| -311.2788% | |
| -984.8532% | |
| -57.8618% | |
| 90.6486% | |
| 94.7663% | |
| 75.3988% | |
| 20.4153% | |
| -158.8625% | |
| -280.8964% | |
| -397.4978% | |
| -211.1992% | |
| 23.0884% | |
| 37.8954% | |
| 24.7679% | |
| -21.5346% | |
| -37.0621% | |
| -30.0095% | |
| -61.7304% | |
| -42.966% | |
| -23.6242% | |
| -30.7991% | |
| -20.1291% | |
| -20.4141% | |
| -38.3502% | |
| -49.003% | |
| -45.3776% | |
| -274.2855% | |
| -397.1075% | |
| -296.2663% | |
| -140.3869% | |
| -11.789% | |
| 56.2996% | |
| 46.6358% |